The MSCI World equity index rose by 0.3%, putting it on the cusp of its first weekly gain in more than a month
Closing Bell: Nifty IT fell 2 per cent followed by 0.7-1 per cent cuts each in Bank, Financial, Metal, Realty and Pharma indices. FMCG and Consumer Durables outperformed with fractional gains
Implementation of airbags in other vehicle segments over the medium term will offer further revenue upside for airbag manufacturers, as per rating agency ICRA
CLOSING BELL: Broader markets, meanwhile, outperformed benchmark indices as Nifty MidCap 100 and Nifty SmallCap 100 indices rose up to 0.4 per cent
Investors will parse the minutes to figure out whether more policy tightening is likely
CLOSING BELL: Broader markets, meanwhile, outperformed benchmark indices as Nifty MidCap 100 and Nifty SmallCap 100 indices surged up to 0.2 per cent
Outperform most global peers even as returns moderate to just over 4% in 2022
From all-time highs to heightened volatility, The second of the yearender series assesses the market's trajectory
The last week of this month is usually a good time for markets as it usually gains in the last five trading days of December and the first two trading days of the New Year
During the week, the Sensex fell 2.4 per cent and the Nifty 2.5 per cent, their worst weekly decline since June 17, 2022
Add to that weak results from chipmaker Micron Technologies Inc., and the session turned into a brutal one for equity bulls, who are again fretting over the risk of a potential recession
Both Sensex and Nifty post biggest losses since Sept 26 as Covid cases in China, oil price spike worsen sentiment
RSBVL, a wholly owned subsidiary of Reliance Industries Limited (RIL), on Thursday acquired 23.3 per cent stake in Exyn Technologies Inc (Exyn) for a total consideration of $25 million
Promoter entities of Ajanta Pharma on Thursday divested 4.3 per cent stake in the company for Rs 637 crore through open market transactions. The buyers included over two dozen funds such as UTI Mutual Fund (MF), Aditya Birla Sun Life MF, Franklin Templeton MF, ICICI Prudential MF, Mirae Asset MF, Abu Dhabi Investment Authority and Tata AIA Life Insurance Company, among others. Aayush Agrawal Trust and Ravi Agrawal Trust offloaded a total of 54,92,846 shares, amounting to 4.3 per cent stake in Ajanta Pharma, as per block deal data with the National Stock Exchange (NSE). The shares were offloaded at an average price of Rs 1,160.1 per scrip, taking the transaction value to Rs 637.22 crore. Following the stake sale, the promoter and promoter group entities' shareholding has come down to 66.18 per cent from 70.48 per cent. Ajanta Pharma's shares closed 5.22 per cent higher at Rs 1,233 apiece on NSE. Mumbai-based Ajanta Pharma is a speciality pharmaceutical formulation company.
Leading stock exchange NSE on Thursday said it has received in-principle approval from capital markets regulator Sebi to set-up a social stock exchange as a separate segment. The National Stock Exchange of India (NSE India) received an in-principle nod from the Securities Exchange Board of India (Sebi) on December 19, it said in a statement. "We are working towards the launch of SSE as a segment on NSE. We believe this platform will immensely benefit the social enterprises contributing to the sustainable development goals," Ashishkumar Chauhan, MD and CEO of NSE, said. The framework for the Social Stock Exchange (SSE), which was notified in July, was developed on the basis of the recommendations of a working group and technical group constituted by the regulator. SSE is a novel concept in India and such a bourse is meant to serve the private and non-profit sectors by channelling greater capital to them. The idea of SSE was first floated by Finance Minister Nirmala Sitharaman in her
Decision by the BOJ, the last dove of the major central banks, has added to concern among investors about how impact of rising interest rates and persistent inflation will affect the global economy
The biggest decline in two months; FPIs sell shares worth Rs 711 cr
Only 2 companies raised more than $500 mn via public offers in 2022
Even seasoned investors should bet only 5-10% on such securities
Here's how leading brokerages and research houses expect 2023 to play out for the equity markets, and their sector preferences